← All trials
NCT04655625
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 23, 2020
- Primary completion
- May 27, 2021
- Completion date
- Mar 31, 2022
- First posted
- Dec 7, 2020
- Last posted
- Dec 7, 2020
- Enrollment
- 500
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- AnGes, Inc.Lead sponsor
- Japan Agency for Medical Research and DevelopmentCollaborator
- AnGes, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.